BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 24410957)

  • 1. Reciprocal regulation of microRNA-99a and insulin-like growth factor I receptor signaling in oral squamous cell carcinoma cells.
    Yen YC; Shiah SG; Chu HC; Hsu YM; Hsiao JR; Chang JY; Hung WC; Liao CT; Cheng AJ; Lu YC; Chen YW
    Mol Cancer; 2014 Jan; 13():6. PubMed ID: 24410957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-99a suppresses cell migration and invasion by regulating IGF1R in gastric cancer.
    Xu XL; Guo AX; Pan QY; Chang AL; Zhao CR
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7375-7382. PubMed ID: 31539124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNA CCAT1 is a prognostic biomarker for the progression of oral squamous cell carcinoma via miR-181a-mediated Wnt/β-catenin signaling pathway.
    Li GH; Ma ZH; Wang X
    Cell Cycle; 2019 Nov; 18(21):2902-2913. PubMed ID: 31599709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-375 Inhibits Growth and Enhances Radiosensitivity in Oral Squamous Cell Carcinoma by Targeting Insulin Like Growth Factor 1 Receptor.
    Zhang B; Li Y; Hou D; Shi Q; Yang S; Li Q
    Cell Physiol Biochem; 2017; 42(5):2105-2117. PubMed ID: 28810236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-99a suppresses proliferation, migration and invasion of esophageal squamous cell carcinoma cells through inhibiting the IGF1R signaling pathway.
    Mei LL; Qiu YT; Huang MB; Wang WJ; Bai J; Shi ZZ
    Cancer Biomark; 2017 Dec; 20(4):527-537. PubMed ID: 28800315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-99a-5p suppresses cell proliferation, migration, and invasion by targeting isoprenylcysteine carboxylmethyltransferase in oral squamous cell carcinoma.
    Sun X; Yan H
    J Int Med Res; 2021 May; 49(5):300060520939031. PubMed ID: 34038200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated microRNA-145 inhibits the development of oral squamous cell carcinoma through inactivating ERK/MAPK signaling pathway by down-regulating HOXA1.
    Ding J; Sun D; Xie P
    Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31138758
    [No Abstract]   [Full Text] [Related]  

  • 8. MiR-148a inhibits oral squamous cell carcinoma progression through ERK/MAPK pathway via targeting IGF-IR.
    Jia T; Ren Y; Wang F; Zhao R; Qiao B; Xing L; Ou L; Guo B
    Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32202300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CiRS-7 functions as a ceRNA of RAF-1/PIK3CD to promote metastatic progression of oral squamous cell carcinoma via MAPK/AKT signaling pathways.
    Dou Z; Gao L; Ren W; Zhang H; Wang X; Li S; Zheng J; Kong X; Chi P; Zhi K
    Exp Cell Res; 2020 Nov; 396(2):112290. PubMed ID: 32956704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-98 suppresses tumor cell growth and metastasis by targeting IGF1R in oral squamous cell carcinoma.
    Du Y; Li Y; Lv H; Zhou S; Sun Z; Wang M
    Int J Clin Exp Pathol; 2015; 8(10):12252-9. PubMed ID: 26722410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-7 targets IGF1R (insulin-like growth factor 1 receptor) in tongue squamous cell carcinoma cells.
    Jiang L; Liu X; Chen Z; Jin Y; Heidbreder CE; Kolokythas A; Wang A; Dai Y; Zhou X
    Biochem J; 2010 Nov; 432(1):199-205. PubMed ID: 20819078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-146a promotes proliferation, invasion, and epithelial-to-mesenchymal transition in oral squamous carcinoma cells.
    Wang F; Ye LJ; Wang FJ; Liu HF; Wang XL
    Environ Toxicol; 2020 Oct; 35(10):1050-1057. PubMed ID: 32469461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA DANCR regulates the growth and metastasis of oral squamous cell carcinoma cells via altering miR-216a-5p expression.
    Qu XH; Shi YL; Ma Y; Bao WW; Yang L; Li JC; Zhang F
    Hum Cell; 2020 Oct; 33(4):1281-1293. PubMed ID: 32860589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long noncoding RNA UCA1 promotes cell growth, migration, and invasion by targeting miR-143-3p in oral squamous cell carcinoma.
    Duan Q; Xu M; Wu M; Zhang X; Gan M; Jiang H
    Cancer Med; 2020 May; 9(9):3115-3129. PubMed ID: 32130788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of microRNA 99a in oral squamous cell carcinomas contributes to the growth and survival of oral cancer cells.
    Yan B; Fu Q; Lai L; Tao X; Fei Y; Shen J; Chen Z; Wang Q
    Mol Med Rep; 2012 Sep; 6(3):675-81. PubMed ID: 22751686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circ-PVT1/miR-106a-5p/HK2 axis regulates cell growth, metastasis and glycolytic metabolism of oral squamous cell carcinoma.
    Zhu X; Du J; Gu Z
    Mol Cell Biochem; 2020 Nov; 474(1-2):147-158. PubMed ID: 32737775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [MiR-99a inhibits proliferation of oral squamous cell carcinoma by targeting mTOR pathway].
    Wang K; Peng GG; Tan YL; He SZ; Luo CF
    Shanghai Kou Qiang Yi Xue; 2021 Feb; 30(1):44-49. PubMed ID: 33907778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knockdown of circ_0011946 targets miR-216a-5p/BCL2L2 axis to regulate proliferation, migration, invasion and apoptosis of oral squamous cell carcinoma cells.
    Zhou Y; Zhang S; Min Z; Yu Z; Zhang H; Jiao J
    BMC Cancer; 2021 Oct; 21(1):1085. PubMed ID: 34620126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-338 suppresses the growth and metastasis of OSCC cells by targeting NRP1.
    Liu C; Wang Z; Wang Y; Gu W
    Mol Cell Biochem; 2015 Jan; 398(1-2):115-22. PubMed ID: 25204970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical value and potential circulating of miR-99a as tumor suppressor biomarker in serum of oral squamous cell carcinoma and erosive atrophic lichen planus.
    Farshbaf A; Mohtasham N; Shamshiri AK; Khazaeni K; Aghaee-Bakhtiari SH; Arab F; Cheshomi M; Hassanabadi M; Mohajertehran F
    J Stomatol Oral Maxillofac Surg; 2024 Jun; 125(3S):101806. PubMed ID: 38408642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.